ISSN: 2475-7640

臨床および実験的移植のジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Postoperative Telemonitoring Following Kidney Transplantation: Effects on Early Hospital Readmissions and Graft Outcomes

Elfadawy N, Sanchez EQ, Ngendahimana D, Love TE, Augustine JJ, Woodside KJ, Humphreville VR, Abdalla M, Hricik DE and Sarabu N

Background: Telemonitoring has been recently shown to improve outcomes and reduce hospital admission rate in cardiac patients. Effect of telemonitoring on early hospital readmission and graft outcomes in kidney transplant population is not well studied.
Methods: In this retrospective observational study, we compared 167 kidney transplant recipients who were discharged with telemonitoring to 191 historic controls with no telemonitoring. All telemonitored patients were monitored with the use of CardioCom device, by a registered nurse trained in transplant and home care. To assess the impact of the telemonitoring on readmission rate, logistic regression analysis was performed. Survival analysis was conducted to assess impact on one-year graft and patient survival.
Results: Of 358 total patients, 32.1% (n=115) had early readmission. Of these, 56 of the 167 patients (33.5%) with telemonitoring experienced early readmission, compared to 59 of 191 controls (30.9%). Telemonitoring was associated with slightly higher early readmission compared to control group, which was not statistically significant (OR=1.13, 95% CI=0.72-1.76, p=0.59). Telemonitored and control patients had comparable one-year graft and patient survival, 97% vs. 94.2% (HR: 0.51; 95 CI: 0.18-1.48, p=0.22) and 98% vs. 96.3% (HR: 0.32; 95 CI: 0.07-1.55, p=0.14) respectively.
Conclusions: Early post kidney transplant telemonitoring did not show significant reduction in early hospital admission rate or improvement in 1-year patient/ graft survival.